Wire · regulatory
Montana To Open Up Unapproved, Experimental Drugs To Consumers
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 16 September 2026 · Fusion42 review
Montana passed a law allowing consumer access to unapproved, experimental drugs via a private board, requiring patient consent, provider recommendation, and payment, raising concerns about FDA penalties and patient safety.
This Wire brief sits within Fusion42's coverage of Biotech, and 2 sources have reported it between 16 Sep 2026 and 18 Sep 2026.
◆ ◆ The Wire takeaway
You face a new regulatory frontier where unapproved drugs can reach consumers in Montana, challenging FDA conventions and exposing your firm to compliance risks or new market openings.
◆ Coverage
2 sources · first reported 16 Sep 2026 · latest 18 Sep 2026
◆ Related on Wire
◆ Topics